EUVIMEDEUVIMED entdecken
EditorialOpen Access · CC BY 4.0

Therapeutic Drug Monitoring and Adverse Drug Reactions: From Signal Detection to Prevention

Engi Algharably iD, Ursula Gundert-Remy

Pharmaceuticals · 19.08.2026 · 19 (8) · 1308

DOI: 10.3390/ph19081308 ↗

Kurz gefasst

Editorial in der Zeitschrift Pharmaceuticals, online erschienen am 19.08.2026. Verfasst von Engi Algharably und 1 weiteren Autor:innen. Beteiligte Einrichtung: Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Institute of Clinical Pharmacolo…. Die Arbeit nennt 5 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Optimizing pharmacotherapy is a central goal of clinical pharmacology [...]

Autor:innen und Institutionen

  • Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Institute of Clinical Pharmacology and Toxicology, Charitéplatz 1, 10117 Berlin, Germany.

ORCID-Profile: Engi Algharably

Zitieren

APA

Algharably, E., & Gundert-Remy, U. (2026). Therapeutic Drug Monitoring and Adverse Drug Reactions: From Signal Detection to Prevention. Pharmaceuticals, 19(8), 1308. https://doi.org/10.3390/ph19081308

Vancouver

Algharably E, Gundert-Remy U. Therapeutic Drug Monitoring and Adverse Drug Reactions: From Signal Detection to Prevention. Pharmaceuticals. 2026;19(8):1308. doi:10.3390/ph19081308

BibTeX
@article{Algharably2026,
  author = {Algharably, Engi and Gundert-Remy, Ursula},
  title = {Therapeutic Drug Monitoring and Adverse Drug Reactions: From Signal Detection to Prevention},
  journal = {Pharmaceuticals},
  year = {2026},
  volume = {19},
  number = {8},
  pages = {1308},
  doi = {10.3390/ph19081308}
}
Kostenlos starten →